ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60.

Slides:



Advertisements
Similar presentations
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Advertisements

Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:
חזק בהגנה לבבית Valsartan in Heart Failure
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
Study flow diagram BB=blockers; HTN=hypertension; RCT=randomized controlled trial Bangalore S. et al. Am J Cardiol. 2007;100:
BluntPenetrating Placebo rFVIIa Patients (%) n=20 n=8 n=9 n=4 P=0.03 P=0.068 Adapted from Rizoli S. Canadian Anesthesiologists’
Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Selective heart rate reduction with ivabradine unloads the left ventricle in.
Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed.
2007May221 Journal Club for Analysis of Complex Datasets Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic,
Shalev V, et al. Arch Intern Med 2009; 169:
Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.
Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Does Elevated C-Reactive Protein Increase Atrial.
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peripheral Artery Disease: Evolving Role of Exercise,
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Introducing High-Sensitivity Cardiac.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Benefits Conferred by Radial Access for Cardiac.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.
Adapted from Weiss et al. J Am Coll Cardiol. 1998;31:
Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;
2013 ACC/AHA cholesterol treatment guidelines
Clinical Characteristics
Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:
Prediction of Cardiovascular Disease by the Framingham‐REGICOR Equation in the High‐Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different.
Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)
NSAIDs: Risk of acute MI compared with remote use
Creatinine clearance (mL/min) n All-cause mortality (%)
Effect of evolocumab on lipoprotein particles
Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors
Median total new lesion volume
Risk of major congenital malformations among study infants according to fetal exposure to antihypertensives during first trimester alone* Variable ACE.
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
2013 ACC/AHA cholesterol treatment guidelines
RE-MODEL and RE-NOVATE : Total VTE and All-cause Mortality
Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.
Mancini JG, et al. Am J Cardiol.
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.
Baseline Characteristics by Baseline N-BNP Level
Patient characteristics: American vs Canadian transplant patients
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Baseline Characteristics of Study Subjects
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Statin Use and Risk of COPD Exacerbation Requiring Hospitalization
Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4), by number of.
Flow chart of search strategy
Davide Capodanno et al. JCIN 2009;2:
Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.
Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.
MRRs and EMRRs for women with ACS
Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.
(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.
Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.
Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:
Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62
Increase of physical activity over time associated with lower HF risk
Multivariable analysis of hospital days and costs for children in the last year of life, by type and number of LT-CCCs. Multivariable analysis of hospital.
The odds ratio comparing phonation to the breath-hold technique is given above the glottis, at the glottis, and below the glottis. The odds ratio comparing.
Prospective associations of beverage consumption with incident type 2 diabetes: random effects meta-analysis. *Unadjusted for adiposity. †Adjusted for.
Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.
Presentation transcript:

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the High-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the Low-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

ACE inhibitors, ARBs and Statins in COPD: Unadjusted Risk Ratios and 95% Confidence Intervals in the High- and Low-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the High-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the Low-Risk COPD Cohorts